Downey Gregory 4
4 · Lexaria Bioscience Corp. · Filed Apr 27, 2021
Insider Transaction Report
Form 4
Downey Gregory
Chief Financial Officer
Transactions
- Award
Stock Options
2021-04-26+5,000→ 25,000 totalExercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying)
Holdings
- 1,833
common shares
- 8,000
Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (8,000 underlying) - 12,000
Stock Options
Exercise: $5.04From: 2021-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 16,000
Stock Options
Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying) - 20,000
Stock Options
Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)